Thomas Zindrick
Chief Executive Officer at GENELUX CORPORATION
Net worth: 48 641 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Bradway | M | 61 | 18 years | |
| James Tyree | M | 71 | 12 years | |
| John Smither | M | 71 | 8 years | |
| Mark A. Bertagnolli | M | - |
Amitech Therapeutic Solutions, Inc
| 13 years |
| Jeffrey P. Draime | M | 57 |
Aeromics, Inc.
 Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 7 years |
| Lourie Zak | M | 61 | 1 years | |
| Sean Ryder | M | 54 | 3 years | |
| Mary Mirabelli | F | 67 | 3 years | |
| Esteban Santos | M | 56 | 17 years | |
| Robert Eckert | M | 69 | 21 years | |
| David Reese | M | 61 | 19 years | |
| John Thomas | M | 66 | 22 years | |
| Joseph Cappello | M | 67 | 12 years | |
| Matthew Busch | M | 50 | 20 years | |
| Kim Duffy | F | - | - | |
| Peter C. Agre | M | - |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 5 years |
| Paul Scigalla | M | 79 | 13 years | |
| Derek Miller | M | - | 21 years | |
| Mark Day | M | 52 |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 6 years |
| Mike Zahigian | M | - | 23 years | |
| Dave Jenkins | M | - |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 5 years |
| Ralph Smalling | M | 68 | 1 years | |
| Tony Yu | M | 53 | 22 years | |
| Qian Zhang | M | 60 | 21 years | |
| Peter Longo | M | - |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 8 years |
| Caroline Jewett | F | 59 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Dennis Fenton | M | 72 | 27 years | |
| Marc F. Pelletier | M | 53 |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 12 years |
| Pamela Wapnick | F | 58 | 9 years | |
| Paul Eisenberg | M | - | 14 years | |
| David W. Beier | M | 75 | 10 years | |
| Michael Kelly | M | 67 | 14 years | |
| Kathryn Falberg | F | 63 | 6 years | |
| Frank J. Biondi | M | 79 | 15 years | |
| William Ashton | M | 73 | 16 years | |
| James Daly | M | 63 | 9 years | |
| Preston Klassen | M | 55 | 7 years | |
| Sean B. W. Martin | M | 61 | - | |
| John Moriarty | M | 56 | 6 years | |
| Diana McKenzie | F | 59 | 12 years | |
| Sean E. Harper | M | 61 | 16 years | |
| Michael Severino | M | 58 | 10 years | |
| Gregory L. Tewalt | M | - | - | |
| Cynthia Flowers | F | 64 | 5 years | |
| Vasant Prakash Gandhi | M | - | 5 years | |
| Craig Shepherd | M | - | 7 years | |
| Cynthia Patton | F | 62 | 15 years | |
| Willard Dere | M | 70 | 11 years | |
| Marco Renoldi | M | 67 | 3 years | |
| Joseph Newell | M | 54 | 7 years | |
| Susan Lundeen Smuck | F | 57 | 12 years | |
| Erin Lavelle | F | 46 | 15 years | |
| Andreas Grauer | M | 63 | - | |
| Nathan Hardy | M | 48 | 10 years | |
| William P. Sheridan | M | 69 | 5 years | |
| Leonard Schaeffer | M | 78 | 9 years | |
| François de Carbonnel | M | 78 | 10 years | |
| J. Reason | M | 83 | 12 years | |
| George Morrow | M | 72 | 10 years | |
| David J. Scott | M | 71 | - | |
| Brian M. McNamee | M | 67 | - | |
| Timothy Martin | M | 55 | 3 years | |
| Dominique Monnet | M | 65 | 11 years | |
| Frank Herringer | M | 81 | 15 years | |
| Vance D. Coffman | M | 79 | 9 years | |
| Anna Richo | F | 63 | - | |
| Patricia Cary Sueltz | F | 71 | 2 years | |
| George A. Vandeman | M | 84 | - | |
| Doug Samuelson | M | 64 | - | |
| Jin Long Chen | M | 61 | 4 years | |
| Martha E. Vincent | M | - | 9 years | |
| George Morstyn | M | 73 | 11 years | |
| Frederick A. Fletcher | M | - | 10 years | |
| Juan Jaen | M | 66 | 10 years | |
| Bradley J. Maroni | M | 71 | 6 years | |
| Brian Kotzin | M | 74 | 11 years | |
| Stuart Tross | M | 57 | 10 years | |
| Kevin L. Stark | M | - | 15 years | |
| James Scott Whitehurst | M | 58 | 8 years | |
| Diane Parks | F | 71 | 7 years | |
| Timothy Powers | M | 58 | 5 years | |
| Nick Abbott | M | - | 10 years | |
| James G. Stout | M | 58 | 4 years | |
| Jude Dinges | M | - | - | |
| David Hallal | M | 57 | 10 years | |
| Marc D. Better | M | 68 | 5 years | |
| Michael Narachi | M | 64 | 20 years | |
| Urte Gayko | M | 53 | 9 years | |
| Jesse Seton McGreivy | M | 54 | 6 years | |
| Terry Rosen | M | 65 | 9 years | |
| William Marshall | M | 60 | 10 years | |
| Majed Kheir | M | 46 | 6 years | |
| Peter K. Watler | M | 62 | 12 years | |
| Andrew Knudten | M | - | 13 years | |
| Richard Davies | M | 62 | 9 years | |
| Pirow Bekker | M | 63 | 8 years | |
| Joshua J. Ofman | M | 60 | 16 years | |
| Brian Lian | M | - | 3 years | |
| Steven J. Ruhl | M | - | - | |
| David A. Boyden | M | 63 | 13 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thomas Zindrick
- Personal Network
